neostigmine has been researched along with Genetic Predisposition in 1 studies
Neostigmine: A cholinesterase inhibitor used in the treatment of myasthenia gravis and to reverse the effects of muscle relaxants such as gallamine and tubocurarine. Neostigmine, unlike PHYSOSTIGMINE, does not cross the blood-brain barrier.
neostigmine : A quaternary ammonium ion comprising an anilinium ion core having three methyl substituents on the aniline nitrogen, and a 3-[(dimethylcarbamoyl)oxy] substituent at position 3. It is a parasympathomimetic which acts as a reversible acetylcholinesterase inhibitor.
| Excerpt | Relevance | Reference |
|---|---|---|
| "The authors describe two patients with congenital myasthenic syndrome (CMS) with end plate acetylcholinesterase (AChE) deficiency caused by mutations in the collagenic tail (ColQ) of AChE: a homozygous C-terminal Y230S mutation in Patient 1 and Y430S and a C-terminal splice-site mutation in Patient 2." | 1.33 | Congenital endplate acetylcholinesterase deficiency responsive to ephedrine. ( Bestue-Cardiel, M; Capablo-Liesa, JL; Engel, AG; López-Pisón, J; Martin-Martinez, J; Peña-Segura, JL; Sáenz de Cabezón-Alvarez, A, 2005) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bestue-Cardiel, M | 1 |
| Sáenz de Cabezón-Alvarez, A | 1 |
| Capablo-Liesa, JL | 1 |
| López-Pisón, J | 1 |
| Peña-Segura, JL | 1 |
| Martin-Martinez, J | 1 |
| Engel, AG | 1 |
1 other study available for neostigmine and Genetic Predisposition
| Article | Year |
|---|---|
Congenital endplate acetylcholinesterase deficiency responsive to ephedrine.
Topics: Acetylcholinesterase; Adolescent; Adrenergic Agents; Child; Cholinesterase Inhibitors; Diagnosis, Di | 2005 |